BioAge Labs Inc (BIOA)’s stock is trading at $6.10 at the moment marking a fall of -0.65% from the last session close. As of this writing, shares are priced at -77.08% less than their 52-week high of $26.62, and 58.44% over their 52-week low of $3.85. Based on the past 30-day period, the stock price is -69.59% below the high and +60.91% above the low.
BIOA’s price to book ratio for the most recent quarter was 0.66, resulting in an 0.65 price to cash per share for the period.
How does BioAge Labs Inc (BIOA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 2.67 in simple terms.
BioAge Labs Inc (NASDAQ: BIOA) Ownership Details
I will give a breakdown of the key shareholders in BioAge Labs Inc (BIOA). Recent figures show that the company’s insiders hold 3.62% of shares. A total of 70 institutional investors hold shares in the company, making 70.74% of its stock and 73.40% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Ah Capital Management, L.L.C. holding total of 3.01 shares that make 8.41% of the company’s total number of shares and are currently priced at 18.39 million.
The securities firm Sofinnova Investments, Inc. holds 2.3 shares of BIOA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 6.43%, and the holding percentage of shares is valued at 14.06 million.
An overview of BioAge Labs Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests BioAge Labs Inc (BIOA) traded 1,642,299 shares per day, with a moving average of $11.05 and price change of -12.94. With the moving average of $17.71 and a price change of -15.51, about 828,446 shares changed hands on average over the past 50 days.
